Early stage bc
Again, the question is: Does the blanket use of chemotherapy for early stage breast cancer patients whose ovarian function is annihilated by chemotherapy actually result in more of them them living longer than those who don't get chemotherapy, or not?
Especially considering that more often than not, the chemotherapy chosen doesn't do much of anything to their particular brand of cancer?
Since HR+'s get less benefit from chemo, is it actually cutting their lifespan shorter to do the chemo?
AlaskaAngel
|